Juvenile Idiopathic Arthritis Guideline

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis

JIA Oligoarthritis, TMJ, and sJIA Guideline Supplementary Appendix 1 – Methods

JIA Oligoarthritis, TMJ, and sJIA Guideline Supplementary Appendix 2 – Search Strategies

JIA Oligoarthritis, TMJ, and sJIA Guideline Supplementary Appendix 3 – Evidence Report

JIA Oligoarthritis, TMJ, and sJIA Guideline Supplementary Appendix 4 – List of Outcomes

JIA Oligoarthritis, TMJ, and sJIA Guideline Supplementary Appendix 5 – Panels/Teams Involved

JIA Oligoarthritis, TMJ, and sJIA Guideline Supplementary Appendix 6 – Study Selection

JIA Oligoarthritis, TMJ, and sJIA Guideline Supplementary Appendix 7 – Research Agenda

JIA Oligoarthritis, TMJ, and sJIA Guideline Project Plan

JIA Oligoarthritis, TMJ, and sJIA Guideline Public Comments

JIA Oligoarthritis, TMJ, and sJIA Guideline Author Response to Public Comments

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging

JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging Guideline Supplementary Appendix 1 – Methods

JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging Guideline Supplementary Appendix 2 – Search Strategies

JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging Guideline Supplementary Appendix 3 – Evidence Report

JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging Guideline Supplementary Appendix 4 – List of Outcomes

JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging Guideline Supplementary Appendix 5 – Panel Teams

JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging Guideline Supplementary Appendix 6 – Study Selection

JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging Guideline Supplementary Appendix 7 – Research Agenda

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis

JIA Guideline Supplementary Appendix 1 – Methods

JIA Guideline Supplementary Appendix 2 – Panel Teams

JIA Guideline Supplementary Appendix 3 – Outcomes Framework

JIA Guideline Supplementary Appendix 4 – Search Strategies

JIA Guideline Supplementary Appendix 5 – Study Selection

JIA Guideline Supplementary Appendix 6 – Evidence Report

JIA Guideline Disclosure Summary

JIA Guideline Project Plan

JIA Guideline Public Comments

JIA Guideline Author Response to Public Comments

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis

JIA Uveitis Guideline Supplementary Appendix 1 – Methods

JIA Uveitis Guideline Supplementary Appendix 2 – Panel Teams

JIA Uveitis Guideline Supplementary Appendix 3 – Search Strategies

JIA Uveitis Guideline Supplementary Appendix 4 – Study Selection

JIA Uveitis Guideline Supplementary Appendix 5 – Evidence Report

JIA Uveitis Guideline Supplementary Appendix 6 – Dropped PICO Questions

JIA Uveitis Guideline Disclosure Summary